The Latest Cardiac and Vascular News
Provides Broad Coverage for Use of TNX-102 for the Treatment of Human Subjects with Any Health Condition Patent Term to 2039, Exclusive of Any Possible Extensions MORRISVILLE, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that […]
Helping patients stick with their care plans and accurately communicate with their providers key to the best quality of life possible, says heart failure nurse specialist PORTLAND, Maine–(BUSINESS WIRE)–A heart failure nurse specialist saw a need for her patients to track the specific metrics needed for their physical well-being, empowering […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces the successful results of the first-in-human early feasibility study of the preCARDIA system. The preCARDIA system is designed to improve decongestion in acutely decompensated heart failure (ADHF) patients by intermittently occluding the superior vena cava. The results of the study published this week in the […]
Most Recent Pre-Clinical Trial Explored Placement in Arterial Branches Seeing Significant Results ISRAEL, Jan. 11, 2022 /PRNewswire/ — HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally invasive cardiac care globally, today announced a major milestone in ongoing pre-clinical trials of the HeartPoint Global Implant System (HPGS) in Israel. Following three […]
– For 30 years, Terumo’s radial access product portfolio has changed the way clinicians perform coronary care procedures – SOMERSET, N.J., Jan. 11, 2022 /PRNewswire/ — Terumo Medical Corporation (TMC) applauds the publication of updated guidelines from the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular […]
New Collaboration Aims to Expand Access to High-Quality, High-Value Cardiovascular Care in South Florida NEW YORK, Jan. 11, 2022 /PRNewswire/ — Novocardia, a value-based cardiovascular care delivery platform, today announced a partnership with My Cardiologist, a trusted provider of cardiovascular services in South Florida for more than 60 years. My Cardiologist employs 27 cardiologists […]
Commencement of regulatory pathway for U.S. market approval OXFORD, England, Jan. 11, 2022 (GLOBE NEWSWIRE) — GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its Pre-Submission for Cardio inCode-SCORE with the Food and Drug Administration (FDA). Cardio inCode-SCORE is an in-vitro […]
American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient response to SGLT2 therapy in 1,325 CANagliflozin CardioVAScular Assessment Study (CANVAS) multinational clinical trial cohort patients NEW YORK and SALT LAKE CITY, Jan. 11, 2022 (GLOBE NEWSWIRE) — Renalytix (NASDAQ: RNLX) (LSE: RENX) announced the publication of positive study results for […]
New code establishes a reimbursement pathway for use of Nanox.AI’s HealthCCSng, designed to promote increased detection of risks for cardiovascular disease in the U.S. population and broader adoption of AI in radiology and population health Achievement follows company’s industry-first code for utilizing AI in imaging with AI detection of vertebral compression […]
Receipt of dedicated CPT® codes mark important commercialization milestone to pursue reimbursement for Prevencio’s multi-protein HART CADhs®, HART CVE®, and HART KD® Blood Tests KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., The AI-driven Cardiac Company™, today announces that the American Medical Association (AMA) has assigned three new, dedicated Current Procedural Terminology (CPT®) Proprietary Laboratory Analysis […]
